Who
Stephen Berenson
Director
Company insider
Files Form 4 as: Director, Seres Therapeutics; Director, Moderna.
In numbers
- Trades disclosed
- 32
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 11 Dec 2018
- Last trade
- 8 Jul 2026
- Last filed
- 10 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 8 Jul 2026filed 10 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,508 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,508 at $0.00 | filing |
| 1 Jul 2025filed 2 Jul 2025 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,470 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 1 Jul 2024filed 3 Jul 2024 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —114,782 at $0.00 | filing |
| 6 May 2024filed 7 May 2024 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,557 at $0.00 | filing |
| 3 May 2024filed 7 May 2024 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —732 at $0.00 | filing |
| 3 May 2024filed 7 May 2024 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —732 | filing |
| 4 Apr 2024filed 8 Apr 2024 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 22 Jun 2023filed 23 Jun 2023 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 3 May 2023filed 5 May 2023 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,601 at $0.00 | filing |
| 3 May 2023filed 5 May 2023 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —732 at $0.00 | filing |
| 28 Apr 2023filed 1 May 2023 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —670 at $0.00 | filing |
| 28 Apr 2023filed 1 May 2023 | MRNA ModernaBiotechnology | SEC FORM 4 Code M | —670 | filing |
| 22 Jun 2022filed 24 Jun 2022 | MCRB Seres Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code M | —703 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,061 at $0.00 | filing |
| 28 Apr 2022filed 2 May 2022 | MRNA Modernaoption or derivative · Biotechnology | SEC FORM 4 Code A | —670 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.